VI
TERN

Vestcor Inc’s Terns Pharmaceuticals TERN Stock Holding History

Vestcor Inc’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-100,000
Closed -$5.27M – 1238
2026
Q1 		$5.27M Buy
+100,000
New +$4.11M 0.15% 149

Other funds holding TERN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Vestcor Inc's TERN Position: Q2 2026 in Review

Vestcor Inc sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 100,000 shares — an estimated $5.27M sold.

Vestcor Inc first reported a position in TERN in Q1 2026 and held it in 1 quarter. The position peaked at $5.27M in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

  • Vestcor Inc reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Vestcor Inc sold 100,000 Terns Pharmaceuticals shares in Q2 2026, an estimated $5.27M.
  • Vestcor Inc first reported a position in Terns Pharmaceuticals in Q1 2026 and held it in 1 quarter.
  • Vestcor Inc's Terns Pharmaceuticals position peaked at $5.27M in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Vestcor Inc's 13F filing for Q2 2026, filed 11 Aug 2026.